Comparative metabolic activation in mouse skin of the weak carcinogen 6-methylchrysene and the strong carcinogen 5-methylchrysene.

We compared the metabolic activation in mouse skin of the weak carcinogen 6-methylchrysene, which lacks a bay region methyl group, and the strong carcinogen 5-methylchrysene, which has a bay region methyl group. Metabolites of 6-methyl-chrysene were prepared using liver homogenates and were identified by their spectral properties and by comparison to synthetic standards as dihydrodiols, hydroxymethyl derivatives, and phenols; their relative levels of formation in liver homogenates from rats and mice were dependent on inducer pretreatment. In mouse skin in vivo, the major metabolite of 6-methyl-chrysene was trans-1,2-dihydro-1,2-dihydroxy-6-methylchrysene (6-MeC-1,2-diol), the precursor to a bay region dihydrodiol epoxide. Its concentration was greater than that of trans-1,2-dihydro-1,2-dihydroxy-5-methylchrysene (5-MeC-1,2-diol) formed in mouse skin from 5-methylchrysene. Since 5-MeC-1,2-diol has been identified as a major proximate carcinogen of 5-methylchrysene, the further metabolism and tumorigenicity of 5-MeC-1,2-diol and 6-MeC-1,2-diol were compared. Both dihydrodiols were converted to 1,2,3,4-tetraols and to 1,2-dihydroxy metabolites to similar extents in mouse skin. However, 5-MeC-1,2-diol was significantly more active than was 6-MeC-1,2-diol as a tumor initiator on mouse skin. The formation of DNA adducts in mouse skin from 5-methylchrysene and 6-methylchrysene was compared. Both hydrocarbons gave qualitatively similar adduct patterns, but the formation of dihydrodiol epoxide type adducts was 1/20 as great from 6-methylchrysene as from 5-methylchrysene. The results of this study indicate that the weak tumorigenicity of 6-methylchrysene compared to that of 5-methylchrysene is not due to differing rates of formation or further metabolism of their 1,2-dihydrodiols but is a likely consequence of the lower activity of 1,2-dihydroxy-3,4-epoxy-1,2,3,4-tetrahydro-6-methylchrysene compared to 1,2-dihydroxy-3,4-epoxy-1,2,3,4-tetrahydro-5-methylchrysene; the unique structural feature of the latter is the presence of a methyl group and an epoxide ring in the same bay region.

[1]  E. LaVoie,et al.  EFFECTS OF METHYL AND FLUORINE SUBSTITUTION ON THE METABOLIC ACTIVATION AND TUMORIGENICITY OF POLYCYCLIC AROMATIC HYDROCARBONS. , 1985 .

[2]  S. Amin,et al.  Rates of hydrolysis and extents of DNA binding of 5-methylchrysene dihydrodiol epoxides. , 1985, Cancer research.

[3]  S. Amin,et al.  Tumorigenicity of 5-methylchrysene dihydrodiols and dihydrodiol epoxides in newborn mice and on mouse skin. , 1985, Cancer research.

[4]  J. Glusker,et al.  The bay-region geometry of some 5-methylchrysenes: steric effects in 5,6- and 5,12-dimethylchrysenes. , 1984, Carcinogenesis.

[5]  S. Amin,et al.  Inhibition by a peri-fluorine atom of 1,2-dihydrodiol formation as a basis for the lower tumorigenicity of 12-fluoro-5-methylchrysene than of 5-methylchrysene. , 1984, Cancer research.

[6]  S. Amin,et al.  Identification of the major adducts formed by reaction of 5-methylchrysene anti-dihydrodiol-epoxides with DNA in vitro. , 1984, Cancer research.

[7]  D. Jerina,et al.  The effect of steric strain in the bay-region of polycyclic aromatic hydrocarbons: tumorigenicity of alkyl-substituted benz[a]anthracenes. , 1983, Cancer letters.

[8]  E. LaVoie,et al.  5-Methylchrysene metabolism in mouse epidermis in vivo, diol epoxide--DNA adduct persistence, and diol epoxide reactivity with DNA as potential factors influencing the predominance of 5-methylchrysene-1,2-diol-3,4-epoxide--DNA adducts in mouse epidermis. , 1983, Carcinogenesis.

[9]  T. Slaga,et al.  Enhancement of the skin tumor-initiating activity of polycyclic aromatic hydrocarbons by methyl-substitution at non-benzo 'bay-region' positions. , 1983, Carcinogenesis.

[10]  R. Harvey,et al.  Carcinogenic metabolites of 5-methylchrysene. , 1983, Carcinogenesis.

[11]  E. LaVoie,et al.  Tumor-initiating activity and metabolism of polymethylated phenanthrenes. , 1982, Cancer research.

[12]  S. Hecht,et al.  Tumor-initiating activity of dihydrodiols formed metabolically from 5-methylchrysene. , 1980, Cancer research.

[13]  P. Fu,et al.  Metabolic and Structural Requirements for the Carcinogenic Potencies of Unsubstituted and Methyl-Substituted Polycyclic Aromatic Hydrocarbons , 1980 .

[14]  S. Amin,et al.  Tumor initiating activity of 5,11-dimethylchrysene and the structural requirements favoring carcinogenicity of methylated polynuclear aromatic hydrocarbons. , 1979, Cancer letters.

[15]  E. LaVoie,et al.  1,2-dihydro-1,2-dihydroxy-5-methylchrysene, a major activated metabolite of the environmental carcinogen 5-methylchrysene. , 1978, Cancer research.

[16]  R. Maronpot,et al.  A study of chemical carcinogenesis: Comparative carcinogenicity of 5-methylchrysene, benzo(a)pyrene, and modified chrysenes , 1975 .

[17]  S. Hecht,et al.  Chrysene and methylchrysenes: presence in tobacco smoke and carcinogenicity. , 1974, Journal of the National Cancer Institute.

[18]  W. Baird,et al.  Isolation of the hydrocarbon-deoxyribonucleoside products from the DNA of mouse embryo cells treated in culture with 7-methylbenz(a)anthracene-3H. , 1973, Cancer research.

[19]  M. Coombs,et al.  Correlation between carcinogenicity and chemical structure in cyclopenta(a)phenanthrenes. , 1973, Cancer research.

[20]  C. Heidelberger,et al.  The carcinogenic activities of various derivatives of dibenzanthracene. , 1962, Cancer research.